Computational studies of difference in binding modes of peptide and non-peptide inhibitors to MDM2/MDMX based on molecular dynamics simulations

Int J Mol Sci. 2012;13(2):2176-2195. doi: 10.3390/ijms13022176. Epub 2012 Feb 17.

Abstract

Inhibition of p53-MDM2/MDMX interaction is considered to be a promising strategy for anticancer drug design to activate wild-type p53 in tumors. We carry out molecular dynamics (MD) simulations to study the binding mechanisms of peptide and non-peptide inhibitors to MDM2/MDMX. The rank of binding free energies calculated by molecular mechanics generalized Born surface area (MM-GBSA) method agrees with one of the experimental values. The results suggest that van der Waals energy drives two kinds of inhibitors to MDM2/MDMX. We also find that the peptide inhibitors can produce more interaction contacts with MDM2/MDMX than the non-peptide inhibitors. Binding mode predictions based on the inhibitor-residue interactions show that the π-π, CH-π and CH-CH interactions dominated by shape complimentarity, govern the binding of the inhibitors in the hydrophobic cleft of MDM2/MDMX. Our studies confirm the residue Tyr99 in MDMX can generate a steric clash with the inhibitors due to energy and structure. This finding may theoretically provide help to develop potent dual-specific or MDMX inhibitors.

Keywords: alanine scanning; binding free energy; molecular dynamics simulation; p53-MDM2/MDMX interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Cell Cycle Proteins
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Ligands
  • Models, Molecular
  • Molecular Dynamics Simulation
  • Molecular Sequence Data
  • Nuclear Proteins* / antagonists & inhibitors
  • Nuclear Proteins* / chemistry
  • Nuclear Proteins* / metabolism
  • Peptides / chemistry*
  • Peptides / metabolism*
  • Protein Binding
  • Protein Structure, Secondary
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins c-mdm2* / antagonists & inhibitors
  • Proto-Oncogene Proteins c-mdm2* / chemistry
  • Proto-Oncogene Proteins c-mdm2* / metabolism
  • Proto-Oncogene Proteins* / antagonists & inhibitors
  • Proto-Oncogene Proteins* / chemistry
  • Proto-Oncogene Proteins* / metabolism
  • Sequence Homology, Amino Acid

Substances

  • Cell Cycle Proteins
  • Ligands
  • MDM4 protein, human
  • Nuclear Proteins
  • Peptides
  • Proto-Oncogene Proteins
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2